• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体外可规避恶性疟原虫耐药性的氨基喹啉。

Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro.

作者信息

De D, Krogstad F M, Cogswell F B, Krogstad D J

机构信息

Department of Tropical Medicine, Tulane University, New Orleans, Louisiana, USA.

出版信息

Am J Trop Med Hyg. 1996 Dec;55(6):579-83. doi: 10.4269/ajtmh.1996.55.579.

DOI:10.4269/ajtmh.1996.55.579
PMID:9025680
Abstract

Aminoquinoline (AQ) resistance is one of the most important factors in the worldwide resurgence of malaria due to Plasmodium falciparum. We synthesized a series of AQs to define the structure-activity relationships responsible for AQ action against chloroquine-susceptible and -resistant P. falciparum. The AQs with ethyl, propyl, isopropyl, butyl, pentyl, isopentyl (chloroquine), hexyl, octyl, decyl, or dodecyl side chains were equally active against chloroquine-susceptible P. falciparum (50% inhibitory concentrations [IC50s] = 5-15 nM). The AQs with ethyl, propyl, isopropyl, decyl, or dodecyl side chains were also active against chloroquine-, mefloquine- and multiply-resistant P. falciparum (IC50s = 5-20 nM). Verapamil, which enhances the activity of chloroquine against chloroquine-resistant parasites, had no effect on the activity of AQs that were active against resistant parasites. These results indicate that AQs with 2-12 carbon side chains are as active as chloroquine against chloroquine-susceptible P. falciparum, and that AQs with side chains shorter or longer than chloroquine are often active against chloroquine-, mefloquine-, and multiply-resistant P. falciparum.

摘要

氨基喹啉(AQ)耐药性是导致恶性疟原虫引起的疟疾在全球范围内再度流行的最重要因素之一。我们合成了一系列氨基喹啉,以确定其对氯喹敏感及耐药的恶性疟原虫发挥作用的构效关系。带有乙基、丙基、异丙基、丁基、戊基、异戊基(氯喹)、己基、辛基、癸基或十二烷基侧链的氨基喹啉对氯喹敏感的恶性疟原虫具有同等活性(50%抑制浓度[IC50s]=5-15 nM)。带有乙基、丙基、异丙基、癸基或十二烷基侧链的氨基喹啉对氯喹、甲氟喹和多重耐药的恶性疟原虫也具有活性(IC50s=5-20 nM)。维拉帕米可增强氯喹对氯喹耐药寄生虫的活性,但对那些对耐药寄生虫具有活性的氨基喹啉的活性没有影响。这些结果表明,带有2-12个碳侧链的氨基喹啉对氯喹敏感的恶性疟原虫的活性与氯喹相当,并且带有比氯喹侧链短或长的氨基喹啉通常对氯喹、甲氟喹和多重耐药的恶性疟原虫具有活性。

相似文献

1
Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro.在体外可规避恶性疟原虫耐药性的氨基喹啉。
Am J Trop Med Hyg. 1996 Dec;55(6):579-83. doi: 10.4269/ajtmh.1996.55.579.
2
Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines.7-取代4-氨基喹啉类化合物抗疟活性的构效关系
J Med Chem. 1998 Dec 3;41(25):4918-26. doi: 10.1021/jm980146x.
3
4-aminoquinolines active against chloroquine-resistant Plasmodium falciparum: basis of antiparasite activity and quantitative structure-activity relationship analyses.4-氨基喹啉类化合物对氯喹抗性疟原虫有效:抗寄生虫活性和定量构效关系分析的基础。
Antimicrob Agents Chemother. 2011 May;55(5):2233-44. doi: 10.1128/AAC.00675-10. Epub 2011 Mar 7.
4
4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum.具有缩短侧链的氯喹4-氨基喹啉类似物对氯喹耐药的恶性疟原虫仍保持活性。
Antimicrob Agents Chemother. 1996 Aug;40(8):1846-54. doi: 10.1128/AAC.40.8.1846.
5
Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain.抗疟原虫活性的新型 4-氨基喹啉衍生物对氯喹抗性株。
Bioorg Med Chem. 2014 Jul 15;22(14):3573-86. doi: 10.1016/j.bmc.2014.05.024. Epub 2014 May 20.
6
4-Aminoquinoline derivatives: Synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites.4-氨基喹啉衍生物的合成及其对氯喹抗性疟原虫的体外和体内抗疟活性。
Eur J Med Chem. 2016 Oct 21;122:394-407. doi: 10.1016/j.ejmech.2016.06.033. Epub 2016 Jun 23.
7
Overcoming drug resistance to heme-targeted antimalarials by systematic side chain variation of 7-chloro-4-aminoquinolines.通过7-氯-4-氨基喹啉的系统侧链变异克服对血红素靶向抗疟药的耐药性。
J Med Chem. 2008 Apr 10;51(7):1995-8. doi: 10.1021/jm800106u. Epub 2008 Mar 18.
8
Incorporation of an intramolecular hydrogen-bonding motif in the side chain of 4-aminoquinolines enhances activity against drug-resistant P. falciparum.在4-氨基喹啉侧链中引入分子内氢键基序可增强对耐药恶性疟原虫的活性。
J Med Chem. 2006 Jul 27;49(15):4535-43. doi: 10.1021/jm0600951.
9
Antimalarials with Benzothiophene Moieties as Aminoquinoline Partners.具有苯并噻吩部分作为氨基喹啉伙伴的抗疟药。
Molecules. 2017 Feb 24;22(3):343. doi: 10.3390/molecules22030343.
10
A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs.从药物化学角度看4-氨基喹啉类抗疟药物
Curr Top Med Chem. 2006;6(5):479-507. doi: 10.2174/156802606776743147.

引用本文的文献

1
Hybrid Molecules as Efficient Drugs against Multidrug-Resistant Malaria Parasites.作为抗多药耐药疟原虫有效药物的杂合分子
ChemMedChem. 2025 Jun 2;20(11):e202500086. doi: 10.1002/cmdc.202500086. Epub 2025 Apr 14.
2
Fighting Plasmodium chloroquine resistance with acetylenic chloroquine analogues.使用炔基氯喹类似物对抗疟原虫氯喹抗性。
Int J Parasitol Drugs Drug Resist. 2022 Dec;20:121-128. doi: 10.1016/j.ijpddr.2022.10.003. Epub 2022 Oct 31.
3
Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro.
探究间日疟原虫肝脏期寄生虫的独特化学敏感性,并在体外证明 8-氨基喹啉自由基治愈活性。
Sci Rep. 2021 Oct 7;11(1):19905. doi: 10.1038/s41598-021-99152-9.
4
Drug susceptibility of in eastern Uganda: a longitudinal phenotypic and genotypic study.乌干达东部结核分枝杆菌的药物敏感性:一项纵向表型和基因型研究。
Lancet Microbe. 2021 Sep;2(9):e441-e449. doi: 10.1016/s2666-5247(21)00085-9. Epub 2021 Jun 18.
5
Intrinsic fluorescence properties of antimalarial pyrido[1,2-]benzimidazoles facilitate subcellular accumulation and mechanistic studies in the human malaria parasite .抗疟吡啶并[1,2-b]苯并咪唑的固有荧光性质促进了人疟原虫的亚细胞积累和机制研究。
Org Biomol Chem. 2020 Nov 4;18(42):8668-8676. doi: 10.1039/d0ob01730b.
6
Unsymmetrical Bisquinolines with High Potency against Malaria.具有高效抗疟活性的不对称双喹啉
Molecules. 2020 May 10;25(9):2251. doi: 10.3390/molecules25092251.
7
Design, synthesis, and antiprotozoal evaluation of new 2,4-bis[(substituted-aminomethyl)phenyl]quinoline, 1,3-bis[(substituted-aminomethyl)phenyl]isoquinoline and 2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivatives.新型 2,4-双[(取代氨甲基)苯基]喹啉、1,3-双[(取代氨甲基)苯基]异喹啉和 2,4-双[(取代氨甲基)苯基]喹唑啉衍生物的设计、合成及抗原生动物活性评价。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):432-459. doi: 10.1080/14756366.2019.1706502.
8
Recent updates in the discovery and development of novel antimalarial drug candidates.新型抗疟候选药物发现与开发的最新进展。
Medchemcomm. 2018 Feb 2;9(3):437-453. doi: 10.1039/c7md00637c. eCollection 2018 Mar 1.
9
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.喹诺利定修饰的 4-氨基喹啉的体内外活性及 ADME-Tox 特征:一种有效的抗疟原虫(恶性疟原虫和间日疟原虫)血期抗疟药。
Molecules. 2017 Dec 1;22(12):2102. doi: 10.3390/molecules22122102.
10
AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.AQ-13(一种试验性抗疟药)与蒿甲醚加本芴醇治疗非复杂恶性疟原虫疟疾的随机、2期、非劣效性临床试验
Lancet Infect Dis. 2017 Dec;17(12):1266-1275. doi: 10.1016/S1473-3099(17)30365-1. Epub 2017 Sep 12.